Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Setmelanotide (Imcivree) licensed for the treatment of obesity caused by specific rare genetic conditions (including pro-opiomelanocortin [POMC] deficiency and leptin receptor deficiency)
In major trials, semaglutide produced about 15% weight loss around 68 weeks, and tirzepatide produced greater weight loss at around 72 weeks in head-to-head comparison
If you experience muscle cramps, weakness, or an irregular heartbeat, consult your healthcare professional
Is SKINVIVE FDA Approved
US$ 22.66
US$ 28.27
US$ 26.28
US$ 20.42
US$ 23.85
US$ 27.65
US$ 27.23
US$ 23.19
US$ 22.60
US$ 24.91
